Laurent Haegeli

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Paulus Kirchhof, A. John Camm, Andreas Goette et al. · New England Journal of Medicine · 2020 · 2K citations · Full text

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

Andreas Rillig, Christina Magnussen, Ann‐Kathrin Ozga et al. · Circulation · 2021 · 228 citations · Full text

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

Stephan Willems, Katrin Borof, Axel Brandes et al. · European Heart Journal · 2021 · 177 citations · Full text

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text